Best Price on List Of Excipients In Pharmaceuticals - Trending Products China High Quality Weight Loss Powder 99% Orlistat CAS 96829-58-2 – Guanlang Detail:
Orlistat (CAS NO.96829-58-2) is a drug designed to treat obesity. It is mainly used for preventing the absorption of fats from the human diet, thereby reducing caloric intake. Besides, it is intended for use in conjunction with a physician-supervised reduced-calorie diet.
| Item | Requirements | Test Results |
| Appearance | while to off-while powder | White powder |
| Identification | HPLC retention time | Conforms |
| Melting Point | 42 ºC -45°C | 42°C-44°C |
| Specific optical rotation | -31.0°~-41.0° | -36.0° |
| Purity by HPLC | no less than 98.0% | 98.5% |
| Total impurity | no more than 2.0% | 1.6% |
| Max Individual impurity | no more than 0.5% | 0.3% |
| Water content%(K&F) | no more than 0.5% | 0.1% |
| Residual solvents | EtOH no more than 0.5% | N.D |
| EtAC no more than 0.5% | N.D | |
| n-Heptane no more than 0.5% | less than 0.1% | |
| Residue on ignition | less than 0.2% | 0.10% |
| Heavy metals as Pb | no more than 20ppm | less than20ppm |
| Assay (HPLC) | no less than 98.0% | 99.60% |
| Conclusion | Meets the Requirements | |
Orlistat is an internationally recognized new form of weight loss drug. Its commercial name is Sainike and first went on sale in New Zealand in 1998. Orlistat is a long-term and highly effective specific gastrointestinal lipase inhibitor, and it is insoluble in water, soluble in chloroform, and easily soluble in ethanol.
Orlistat can be used clinically to treat obesity. Usually, a dose of 120mg is taken three times a day within one hour of a meal. Weight loss begins to occur after two weeks of usage. It can be used continuously for 6-12 months, and its effects will cease to increase after daily dosage exceeds 400mg. This drug is suitable to be used in combination with a low-calorie diet by obese and overweight individuals, and it can also be used as long-term treatment for patients who have faced weight-related risk factors. Orlistat has a long-term weight-control effect that reduces and maintains weight and prevents against rebounding. Using Orlistat can lower the occurrences of weight-related risk factors and diseases, including hypercholesterolemia, type-2 diabetes, impaired glucose tolerance, hyperinsulinemia, and hypertension, and it can reduce the fat content in organs. Orlistat also adjusts blood lipid levels: it can decrease serum triglycerides (TG) and low density lipoprotein cholesterol (LDL-C), and it can increase the ratio of high density lipoproteins to low density lipoproteins in obese patients.
Product detail pictures:
Related Product Guide:
Cooperation
Our target should be to consolidate and enhance the top quality and service of current goods, in the meantime frequently create new products to satisfy diverse customers' calls for for Best Price on List Of Excipients In Pharmaceuticals - Trending Products China High Quality Weight Loss Powder 99% Orlistat CAS 96829-58-2 – Guanlang, The product will supply to all over the world, such as: Auckland, Poland, Pakistan, To work with an excellent items manufacturer, our company is your best choice. Warmly welcome you and opening up the boundaries of communication. We are the ideal partner of your business development and look forward to your sincere cooperation.
Hebei Guanlang Biotechnology Co., Ltd. belongs to Guanlang Group, which was founded in 2007 , located in Shijiazhuang city which is the capital of Hebei Province and hub sector among Beijing Tianjin and Hebei and has advantage of convenient transportation . Our company is a modern high-tech chemical enterprise with Research & Development, production and sales.We have our own factory and lab,also offer customized synthesis service for our customers.
By Henry stokeld from Southampton - 2018.06.09 12:42
The company keeps to the operation concept "scientific management, high quality and efficiency primacy, customer supreme", we have always maintained business cooperation. Work with you,we feel easy!
By Mag from Jeddah - 2018.07.26 16:51
